Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 223 entries
View as:

Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT01386684 Org: User:
Start: 06/28/11 End: 09/08/16 Due: 09/08/17

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01110473 Org: User:
Start: 04/30/10 End: 06/30/13 Due: 06/30/14

A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America

Phase: N/A Priority: Normal
NCT ID: NCT01297504 Org: User:
Start: 02/28/11 End: 08/31/13 Due: 08/31/14

Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population

Phase: N/A Priority: Normal
NCT ID: NCT01782469 Org: User:
Start: 10/31/12 End: 07/31/14 Due: 07/31/15

Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069

Phase: N/A Priority: Normal
NCT ID: NCT01346501 Org: User:
Start: 04/30/11 End: 11/30/14 Due: 11/30/15

Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01134315 Org: User:
Start: 06/30/10 End: 05/31/12 Due: 05/31/13

Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01185301 Org: User:
Start: 10/31/10 End: 09/30/12 Due: 09/30/13

Hydrocodone/Acetaminophen for Acute Pain Following Third Molar Tooth Extraction

Phase: N/A Priority: Normal
NCT ID: NCT00935311 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT00292396 Org: User:
Start: 11/30/05 End: 04/30/08 Due: 04/30/09

Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek Experience

Phase: N/A Priority: Normal
NCT ID: NCT01083186 Org: User:
Start: 06/30/09 End: 01/31/12 Due: 01/31/13

Safety and Effect on Quality of Life/Work Productivity of Humira in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01076205 Org: User:
Start: 01/12/09 End: 09/14/17 Due: 09/14/18

Special Investigation in Patients With Rheumatoid Arthritis (Working Productivity Activity Impairment)

Phase: N/A Priority: Normal
NCT ID: NCT01346488 Org: User:
Start: 06/30/11 End: 01/31/16 Due: 01/31/17

Observational Study to Explore the Effectiveness of Adalimumab Treatment in Conjunction With Utilization of a Patient Support Program (PSP)

Phase: N/A Priority: Normal
NCT ID: NCT01383421 Org: User:
Start: 09/30/11 End: 04/30/16 Due: 04/30/17

Evaluation of Volatile Induction and Maintenance Anesthesia (VIMA) With Sevorane in Adult Patients Required General Anesthesia for Surgery in Terms of Quality of Anesthesia and Its Influence on Cardiovascular System in Common Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01282203 Org: User:
Start: 07/31/11 End: 11/30/11 Due: 11/30/12

Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT01387802 Org: User:
Start: 06/29/11 End: 12/16/19 Due: 12/16/20

Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

Phase: N/A Priority: Normal
NCT ID: NCT00667446 Org: User:
Start: 12/31/08 End: 01/31/13 Due: 01/31/14

Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients

Phase: N/A Priority: Normal
NCT ID: NCT01758289 Org: User:
Start: 01/31/13 End: 11/30/13 Due: 11/30/14

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar Intravenous

Phase: N/A Priority: Normal
NCT ID: NCT01368042 Org: User:
Start: 08/31/11 End: 06/30/13 Due: 06/30/14

Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01202565 Org: User:
Start: 09/30/10 End: 07/31/13 Due: 07/31/14

Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00195663 Org: User:
Start: 12/31/00 End: 04/30/12 Due: 04/30/13

Evaluation of Humira Retention Rate in Psoriasis Patients in Daily Practice and Assessment of Work Productivity and Quality of Life

Phase: N/A Priority: Normal
NCT ID: NCT01169987 Org: User:
Start: 05/31/10 End: 03/31/15 Due: 03/31/16

A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01674725 Org: User:
Start: 08/31/12 End: 10/31/14 Due: 10/31/15

A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and Safety

Phase: N/A Priority: Normal
NCT ID: NCT01712178 Org: User:
Start: 06/30/12 End: 05/31/13 Due: 05/31/14

Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01235689 Org: User:
Start: 02/11/11 End: 01/03/17 Due: 01/03/18

Documentation of Humira in Psoriasis Patients in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01077232 Org: User:
Start: 01/04/08 End: 06/30/19 Due: 06/30/20